Pharmaceuticals

Vyome

Vyome released FY2025 9 Months Earnings on November 14 During-Market EST, Actual Revenue: USD 283.16K, Actual EPS: USD -3.0574

Vyome released FY2025 Q3 earnings during market hours on November 14 (EST), actual revenue USD 34.63 K (forecast USD 0), actual EPS USD -3.0574 (forecast USD -0.11)

Vyome to release FY2025 Q3 earnings report on November 20 During-Market EST, forecast EPS USD -0.11

Vyome Holdings Inc Acquires MIT AI Spinoff Oculo Health

Vyome released FY2024 9 Months Earnings on September 2, 2025 (EST), with actual revenue of USD 195.52K and EPS of USD 0

Vyome released FY2024 Q2 earnings on September 2, 2025 (EST), with actual revenue of USD 34.01K and EPS of USD -0.246

Vyome released FY2025 Semi-Annual Earnings on September 2 (EST), actual revenue USD 248.54K, actual EPS USD 0

Vyome released FY2025 Q2 earnings on September 2, 2025 (EST) with actual revenue of USD 49.95 K and EPS of USD 0

Vyome Holdings Inc revises equity allocation agreement to raise funding to $12 million

Vyome Holdings Completes Merger with Vyome Therapeutics

Vyome released FY2025 Q1 earnings on May 28 (EST), actual revenue USD 198.58 K, actual EPS USD 0

Vyome released FY2024 Q1 earnings on May 28 (EST), actual revenue USD 76.98 K, actual EPS USD -0.0672

Vyome released FY2024 Q4 earnings on April 29, 2025 (EST) with actual revenue of USD 61.43 K and EPS of USD 0

Vyome released FY2023 Q4 earnings on April 29 (EST), actual revenue USD 69.37 K, actual EPS USD 0

Vyome released FY2023 Annual Earnings on April 29, 2025 (EST), with actual revenue of USD 415.94 K and EPS of USD -0.4225

Vyome released FY2024 Annual Earnings on April 29 (EST), actual revenue USD 256.94K, actual EPS USD 0

Vyome released FY2024 Q3 earnings on December 6, 2024 (EST), actual revenue USD 84.53 K, actual EPS USD 0

Vyome released FY2023 Q3 earnings on December 6, 2024 (EST), actual revenue USD 122.73 K, actual EPS USD 0

Vyome released FY2023 9 Months Earnings on December 6, 2024 (EST) with actual revenue of USD 346.57K and EPS of USD -0.2411

Vyome released FY2023 Q1 earnings on October 1, 2024 (EST), with actual revenue of USD 111.92 K and EPS of USD 0

Luminar Tech

Novabay Pharmac

Mint Incorporation

Autozi Internet Tech Global

GD Culture

Impact BioMedical

Tradr 2X Long FLY Daily ETF

Leverage Shares 2X Long CRWV Daily ETF

T-REX 2X Long CRWV Daily Target ETF

礼来

罗氏(ADR)

ROCHE HOLDINGS AG

阿斯利康

诺华制药

诺和诺德公司

中外制药(ADR)

UCB(ADR)

第一三共株式会社(ADR)

大冢制药(ADR)

Style Score

Growth Score

Revenue YoY

Net Profit YoY

Value Score

P/B Ratio

Dividend Ratio

Size Score

Market Cap Score

Market Cap

Revenue Score

Revenue

Multi Score

Profit Score

Profit Margin

Gross Margin

Total Assets YoY

Net Assets YoY

Cash Score

Cash Flow Margin

OCF YoY

Operating Score

Turnover

Debt Score

Gearing Ratio

Please note that a "Suspected value trap" is a stock that appears The stock looks financially sound and severely undervalued, but behind the low valuation is a long-term decline in business capacity or a serious financial crisis, or even the risk of bankruptcy in the short term.

Suspected value trap